Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease — Etsuro Matsubara (2003) | RDL Network
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
Article 2003 en
Authors
EM
Etsuro Matsubara
TB
Tara Bryant‐Thomas
JP
Javier Pacheco
Abstract
1 min read
The authors wish to make a correction to the above article that was published in J. Neurochem. 85, pp. 11011108. Authors Daniel G. Chain and Eyal Neria were omitted and this has been amended above. The authors also wish to acknowledge that this work has been supported by a NIA grant AG 16783 and by Mindset BioPharmaceuticals (USA) Inc.
Etsuro Matsubara, Tara Bryant‐Thomas, Javier Pacheco Quinto, Tracey L. Henry, Burkhard Pöeggeler, Donald E. Herbert, Felix Cruz-Sánchez, Yau‐Jan Chyan, Mark A. Smith, George Perry, Mikio Shoji, Kōji Abe, Anna Leone, Inge Grundke‐Ikbal, Glen L. Wilson, Jorge Ghiso, Christina Williams, Lorenzo M. Refolo, Miguel A. Pappolla
Gjumrakch Aliev, Dilara Seyidova, Bruce T. Lamb, Mark E. Obrenovich, Sandra L. Siedlak, Harry V. Vinters, Robert P. Friedland, Sandra L. Siedlak, Harry V. Vinters, Robert P. Friedland, Joseph C. LaManna, Mark A. Smith, George Perry
Discussion(0)
No comments yet. Be the first to comment.